MP4, a new nonvasoactive PEG‐Hb conjugate
暂无分享,去创建一个
[1] R. Shorr,et al. The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. , 2008, Artificial organs.
[2] R. Koehler,et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. , 2002, Journal of applied physiology.
[3] A. Popel,et al. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. , 2002, American journal of physiology. Heart and circulatory physiology.
[4] K. Vandegriff,et al. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. , 2001, Biophysical chemistry.
[5] K. Vandegriff. Haemoglobin-based oxygen carriers , 2000, Expert opinion on investigational drugs.
[6] S. Takeoka,et al. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. , 2000, American journal of physiology. Heart and circulatory physiology.
[7] R. Winslow. αα–Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing? , 2000, Vox Sanguinis.
[8] R. Winslow. αα‐Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing? , 2000, Vox sanguinis.
[9] M. Goldman. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial , 2000 .
[10] D. Gens,et al. Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial , 1999 .
[11] M. Kaste,et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. , 1999, Stroke.
[12] Hiromi Sakai,et al. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. , 1998, American journal of physiology. Heart and circulatory physiology.
[13] K. Vandegriff,et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. , 1998, Journal of applied physiology.
[14] J. Olson,et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin , 1998, Nature Biotechnology.
[15] K. Vandegriff,et al. Arterial Blood Pressure Responses to Cell-free Hemoglobin Solutions and the Reaction with Nitric Oxide* , 1998, The Journal of Biological Chemistry.
[16] K. Vandegriff,et al. Hemoglobin-oxygen equilibrium curves measured during enzymatic oxygen consumption. , 1998, Analytical biochemistry.
[17] K. Vandegriff,et al. Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated. , 1997, Biophysical chemistry.
[18] F. Pieruzzi,et al. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. , 1997, The Journal of laboratory and clinical medicine.
[19] K. Vandegriff,et al. Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. , 1997, Journal of applied physiology.
[20] R. Winslow,et al. Microvascular and tissue oxygen distribution. , 1996, Cardiovascular research.
[21] K. Vandegriff,et al. Equilibrium oxygen binding to human hemoglobin cross-linked between the alpha chains by bis(3,5-dibromosalicyl) fumarate. , 1989, The Journal of biological chemistry.
[22] S. Snell,et al. A convenient spectroscopic method for the estimation of hemoglobin concentrations in cell-free solutions. , 1988, Journal of biochemical and biophysical methods.
[23] P. Keipert,et al. Cross-linked Stroma-free Polyhemoglobin as a Potential Blood Substitute , 1982, The International journal of artificial organs.
[24] R. Tuma,et al. Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. , 1980, Microvascular research.
[25] J. Arnold,et al. A clinical safety trial of stroma‐free hemoglobin , 1978, Clinical pharmacology and therapeutics.
[26] R L Berger,et al. Oxygen equilibrium curve of normal human blood and its evaluation by Adair's equation. , 1977, The Journal of biological chemistry.
[27] V. E. Ayers,et al. Determination of the reactive sulfhydryl groups in heme proteins with 4,4'-dipyridinedisulfide. , 1969, Analytical biochemistry.
[28] R. Winslow. New transfusion strategies: red cell substitutes. , 1999, Annual review of medicine.
[29] A. Pope,et al. Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries , 1999 .
[30] K. Vandegriff,et al. Hemoglobin Oxygen Affinity and the Design of Red Cell Substitutes , 1997 .
[31] K. Vandegriff,et al. A Theoretical Analysis of Oxygen Transport: A New Strategy for the Design of Hemoglobin-Based Red Cell Substitutes , 1995 .
[32] R. Winslow,et al. Pilot-scale preparation of hemoglobin solutions. , 1994, Methods in enzymology.
[33] C. Mackenzie. Hemoglobin-based Red Cell Substitutes , 1993 .
[34] Winslow Rm,et al. The intravascular persistence of crosslinked human hemoglobin. , 1989 .
[35] R. Winslow,et al. The intravascular persistence of crosslinked human hemoglobin. , 1989, Progress in clinical and biological research.
[36] T. Chang,et al. Pyridoxylated-polyhemoglobin solution: a low viscosity oxygen-delivering blood replacement fluid with normal oncotic pressure and long-term storage feasibility. , 1988, Biomaterials, artificial cells, and artificial organs.
[37] R. Benesch. Preparation and properties of hemoglobin modified with derivatives of pyridoxal. , 1981, Methods in enzymology.
[38] M. Perutz,et al. Three dimensional fourier synthesis of horse deoxyhaemoglobin at 2.8 Angstrom units resolution. , 1970, Nature.
[39] W. R. Amberson,et al. Clinical experience with hemoglobin-saline solutions. , 1947, Year book - American Philosophical Society.